Literature DB >> 26137157

Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma.

Zhang Zhao1, Guang-Yong Chen2, Jiang Long3, Hai Li4, Jian Huang5.   

Abstract

Chromosomal loci with genomic imbalances are frequently identified in hepatocellular carcinoma (HCC). Greater than two-thirds of hepatitis B virus (HBV)-related HCCs originate from liver cirrhosis following a duration of up to two decades. However, it is unclear whether these genomic imbalances occur and accumulate in dysplastic hepatocytes of the cirrhotic liver during the progression from regenerated nodules to preneoplastic lesions, including dysplastic nodules (DN). In the present study, high-grade DNs (HGDNs) of HBV-related liver cirrhosis were screened to identify loci with genomic imbalances, and the frequency of the identified loci in a group of HCCs was analyzed in order to determine whether there may be a genetic link between liver cirrhosis and HCC. Genomic DNA was extracted from six HGDNs of two cases of HBV-related liver cirrhosis and subjected to array comparative genomic hybridization (CGH) analysis with a NimbleGen 720K microarray. Loci with the most frequently observed genomic imbalances in DNs were further analyzed in 83 cases of HCC by differential polymerase chain reaction (PCR) and quantitative PCR. The array CGH analysis revealed that the majority of genomic imbalances in the HGDNs were genomic losses of small segments, with loss of heterozygosity (LOH) at 5q13.2 and 8p23.1 identified most frequently. Of the 83 HCC cases, 30 (36.1%) cases were identified with LOH at 5q13.2, where known tumor-associated genes are located, including general transcription factor IIH subunit 2 (GTF2H2), baculoviral IAP repeat-containing protein 1 (BIRC1) and occludin (OCLN). LOH frequency at 8p23.1 in HCC was 61.29% (D8S1130) and 68.4% (D8S503) respectively, similar to the results obtained in previous studies. In conclusion, the results of the present study provided evidence that genomic losses at 5q13.2 and 8p23.1 identified in dysplastic hepatocytes of the cirrhotic liver are common events in HCC. HCC-associated chromosomal abnormalities may occur and accumulate in preneoplastic lesions of liver cirrhosis.

Entities:  

Keywords:  5q13.2; dysplastic nodule; genomic imbalances; hepatocellular carcinoma; loss of heterozygosity

Year:  2015        PMID: 26137157      PMCID: PMC4473700          DOI: 10.3892/ol.2015.3140

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Maternal transmission of interstitial microdeletion in 5q13.2 detected during prenatal diagnosis of coarctation of the aorta.

Authors:  Chih-Ping Chen; Chen-Ju Lin; Chen-Yu Chen; Schu-Rern Chern; Peih-Shan Wu; Jun-Wei Su; Wayseen Wang
Journal:  Taiwan J Obstet Gynecol       Date:  2013-06       Impact factor: 1.705

2.  Clinical implication of recurrent copy number alterations in hepatocellular carcinoma and putative oncogenes in recurrent gains on 1q.

Authors:  Tae-Min Kim; Seon-Hee Yim; Seung-Hun Shin; Hai-Dong Xu; Yu-Chae Jung; Cheol-Keun Park; Jong-Young Choi; Won-Sang Park; Mi-Seon Kwon; Heike Fiegler; Nigel P Carter; Mun-Gan Rhyu; Yeun-Jun Chung
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

3.  The tight junction protein, occludin, regulates the directional migration of epithelial cells.

Authors:  Dan Du; Feilai Xu; Lihou Yu; Chenyi Zhang; Xuefeng Lu; Haixin Yuan; Qin Huang; Fan Zhang; Hongyan Bao; Lianghui Jia; Xunwei Wu; Xueliang Zhu; Xiaohui Zhang; Zhe Zhang; Zhengjun Chen
Journal:  Dev Cell       Date:  2010-01-19       Impact factor: 12.270

4.  Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma.

Authors:  P Pineau; H Nagai; S Prigent; Y Wei; G Gyapay; J Weissenbach; P Tiollais; M A Buendia; A Dejean
Journal:  Oncogene       Date:  1999-05-20       Impact factor: 9.867

5.  Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Authors:  P E Zondervan; J Wink; J C Alers; J N IJzermans; S W Schalm; R A de Man; H van Dekken
Journal:  J Pathol       Date:  2000-10       Impact factor: 7.996

6.  Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Authors:  Sanjay Kakar; Xin Chen; Coral Ho; Lawrence J Burgart; Oyedele Adeyi; Dhanpat Jain; Viabhav Sahai; Linda D Ferrell
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

7.  High-density allelotyping of chromosome 8p in hepatocellular carcinoma and clinicopathologic correlation.

Authors:  Kok-Lung Chan; Joyce Man-Fong Lee; Xin-Yuan Guan; Sheung-Tat Fan; Irene Oi-Lin Ng
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

8.  Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.

Authors:  Yoon Seob Kahng; Youn Soo Lee; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Gastroenterol Hepatol       Date:  2003-04       Impact factor: 4.029

9.  A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.

Authors:  Xu Guo; Xi Ma; Jiaze An; Yukui Shang; Qichao Huang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

10.  Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis.

Authors:  F Niketeghad; H J Decker; W H Caselmann; P Lund; F Geissler; H P Dienes; P Schirmacher
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

View more
  2 in total

Review 1.  Latest developments in precancerous lesions of hepatocellular carcinoma.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang; Jing Zhao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

Review 2.  Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics.

Authors:  Rocio I R Macias; Maria J Monte; Maria A Serrano; Jesús M González-Santiago; Isabel Martín-Arribas; André L Simão; Rui E Castro; Javier González-Gallego; José L Mauriz; Jose J G Marin
Journal:  Aging (Albany NY)       Date:  2021-10-11       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.